Lumibird SA (LBIRD.PA)

EUR 9.06

(-1.95%)

Total Liabilities Summary of Lumibird SA

Lumibird SA's latest annual total liabilities in 2023 was 207.98 Million EUR , up 18.94% from previous year.
Lumibird SA's latest quarterly total liabilities in 2024 Q2 was 221.3 Million EUR , up 6.41% from previous quarter.
Lumibird SA reported annual total liabilities of 174.86 Million EUR in 2022, up 7.6% from previous year.
Lumibird SA reported annual total liabilities of 162.5 Million EUR in 2021, up 17.72% from previous year.
Lumibird SA reported quarterly total liabilities of 207.98 Million EUR for 2023 Q4, up 14.41% from previous quarter.
Lumibird SA reported quarterly total liabilities of 181.77 Million EUR for 2023 Q2, up 3.95% from previous quarter.

Annual Total Liabilities Chart of Lumibird SA (2023 - 2009)

Historical Annual Total Liabilities of Lumibird SA (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	207.98 Million EUR	18.94%
2022	174.86 Million EUR	7.6%
2021	162.5 Million EUR	17.72%
2020	138.04 Million EUR	100.62%
2019	68.81 Million EUR	14.19%
2018	60.25 Million EUR	29.52%
2017	46.52 Million EUR	51.25%
2016	30.75 Million EUR	-9.61%
2015	34.02 Million EUR	7.59%
2014	31.62 Million EUR	-2.2%
2013	32.33 Million EUR	-11.35%
2012	36.47 Million EUR	-4.84%
2011	38.33 Million EUR	3.46%
2010	37.04 Million EUR	-2.26%
2009	37.9 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	221.3 Million EUR	6.41%
2023 Q4	207.98 Million EUR	14.41%
2023 Q2	181.77 Million EUR	3.95%
2023 FY	207.98 Million EUR	18.94%
2022 Q4	174.86 Million EUR	3.68%
2022 Q2	168.65 Million EUR	3.78%
2022 FY	174.86 Million EUR	7.6%
2021 Q2	139.08 Million EUR	0.41%
2021 Q4	162.5 Million EUR	16.84%
2021 FY	162.5 Million EUR	17.72%
2020 FY	138.04 Million EUR	100.62%
2020 Q2	136.01 Million EUR	97.67%
2020 Q4	138.51 Million EUR	1.83%
2019 Q4	68.81 Million EUR	8.9%
2019 Q2	63.18 Million EUR	4.86%
2019 FY	68.81 Million EUR	14.19%
2018 Q4	60.25 Million EUR	37.71%
2018 Q2	43.75 Million EUR	0.79%
2018 FY	60.25 Million EUR	29.52%
2017 Q4	43.41 Million EUR	63.04%
2017 FY	46.52 Million EUR	51.25%
2017 Q2	26.62 Million EUR	-13.43%
2016 Q2	28.38 Million EUR	-16.58%
2016 FY	30.75 Million EUR	-9.61%
2016 Q4	30.75 Million EUR	8.35%
2015 Q4	34.02 Million EUR	13.22%
2015 FY	34.02 Million EUR	7.59%
2015 Q2	30.05 Million EUR	-4.97%
2014 FY	31.62 Million EUR	-2.2%
2014 Q4	31.62 Million EUR	0.36%
2014 Q2	31.51 Million EUR	-2.54%
2013 Q4	32.33 Million EUR	-3.28%
2013 FY	32.33 Million EUR	-11.35%
2013 Q2	33.43 Million EUR	-8.34%
2012 Q2	35.08 Million EUR	-8.48%
2012 Q4	36.47 Million EUR	3.98%
2012 FY	36.47 Million EUR	-4.84%
2011 Q2	38.12 Million EUR	2.9%
2011 Q4	38.33 Million EUR	0.54%
2011 FY	38.33 Million EUR	3.46%
2010 FY	37.04 Million EUR	-2.26%
2010 Q4	37.04 Million EUR	4.25%
2010 Q2	35.53 Million EUR	-6.24%
2009 FY	37.9 Million EUR	0.0%
2009 Q2	38.55 Million EUR	0.0%
2009 Q4	37.9 Million EUR	-1.69%

Peer Total Liabilities Comparison of Lumibird SA

Name	Total Liabilities	Total Liabilities Difference
Biosynex SA	117.41 Million EUR	-77.135%
Predilife S.A.	8.3 Million EUR	-2404.301%
bioMérieux S.A.	1.5 Billion EUR	86.2%
Eurofins Scientific SE	6.75 Billion EUR	96.919%